Vitrolife AB, headquartered in Sweden, is a leading player in the reproductive health industry, specialising in products and services for assisted reproductive technology (ART). Founded in 1994, the company has established a strong presence in key operational regions, including Europe, North America, and Asia. Vitrolife is renowned for its innovative solutions, including culture media, cryopreservation products, and laboratory equipment designed to enhance the success rates of IVF treatments. Their commitment to quality and research has positioned them as a trusted partner for fertility clinics worldwide. With a focus on advancing reproductive medicine, Vitrolife continues to achieve significant milestones, solidifying its reputation as a pioneer in the field.
How does Vitrolife's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Vitrolife's score of 40 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Vitrolife, headquartered in Sweden, reported total carbon emissions of approximately 21,000,000 kg CO2e. This figure includes 727,000 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources, and 1,360,000 kg CO2e from Scope 2 emissions, related to the purchase of electricity. The majority of their emissions, about 19,736,000 kg CO2e, fall under Scope 3, which includes indirect emissions from the value chain. Comparatively, in 2022, Vitrolife's emissions were consistent, with 727,000 kg CO2e from Scope 1, 1,360,000 kg CO2e from Scope 2, and 19,736,000 kg CO2e from Scope 3. In 2021, the figures were similar, indicating a stable emissions profile over these years. Vitrolife has committed to near-term climate targets, although specific reduction targets have not been disclosed. The company is actively engaged in sustainability efforts within the healthcare equipment and supplies sector, reflecting a commitment to addressing climate change. Their emissions intensity, measured in relation to revenue, shows a gradual improvement, indicating efforts to decouple growth from carbon emissions. Overall, Vitrolife's emissions data and commitments highlight their ongoing focus on sustainability and climate responsibility in their operations.
Access structured emissions data, company-specific emission factors, and source documents
2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Scope 1 | 515,000 | 000,000 | 000,000 | 000,000 |
Scope 2 | 702,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Scope 3 | 1,199,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Vitrolife is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.